Mechanism and disease association of E2-conjugating enzymes: Lessons from UBE2T and UBE2L3

Biochemical Journal

Volumn 473, Issue 20, 2016, Pages 3401-3419

  Alpi, Arno F ^a   Chaugule, Viduth ^a   Walden, Helen ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HOIP ENZYME; UBE2L3 ENZYME; UBE2T ENZYME; UBIQUITIN; UBIQUITIN CONJUGATING ENZYME E2; UNCLASSIFIED DRUG; UBE2L3 PROTEIN, HUMAN; UBE2T PROTEIN, HUMAN; UBIQUITIN CONJUGATING ENZYME; UBIQUITIN PROTEIN LIGASE;

AUTOIMMUNE DISEASE; CANCER INHIBITION; CARCINOGENESIS; DISEASES; ENZYME MECHANISM; ENZYME STRUCTURE; FANCONI ANEMIA; HUMAN; NEOPLASM; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; ANIMAL; BIOLOGICAL MODEL; ENZYMOLOGY; METABOLISM;

ANIMALS; AUTOIMMUNE DISEASES; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; UBIQUITIN-CONJUGATING ENZYMES; UBIQUITIN-PROTEIN LIGASES;

EID: 84994589276     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BCJ20160028     Document Type: Review

References (190)

1. Pickart, C.M. (2001) Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70, 503-533 doi:10.1146/annurev.biochem.70.1.503
2. Sloper-Mould, K.E, Jemc, J.C., Pickart, CM. and Hicke, L. (2001) Distinct functional surface regions on ubiquitin. J. Biol. Chem. 276, 30483-30489 doi:10.1074/jbc.M103248200
3. Kulathu, Y. and Komander, D. (2012) Atypical ubiquitylation - the unexplored world of polyubiquitin beyond Lys48 and Lys63 linkages. Nat. Rev. Mol. Cell Biol. 13, 508-523 doi:10.1038/nrm3394
4. Alfano, C, Faggiano, S. and Pastore, A. (2016) The ball and chain of polyubiquitin structures. Trends Biochem. Sci. 41, 371-385 doi:10.1016/j.tibs.2016.01.006
5. Husnjak, K. and Dikic, I. (2012) Ubiquitinbinding proteins: decoders of ubiquitin-mediated cellular functions. Annu. Rev. Biochem. 81, 291-322 doi:10.1146/annurev-biochem-051810-094654
6. Clague, M.J., Barsukov, I., Coulson, J.M., Liu, H., Rigden, D.J. and Urbe, S. (2013) Deubiquitylases from genes to organism. Physiol. Rev. 93, 1289-1315 doi:10.1152/physrev.00002.2013
7. Enchev, R.I., Schulman, B.A and Peter, M. (2014) Protein neddylation: beyond cullin-RING ligases. Nat. Rev. Mol. Cell Biol. 16, 30-44 doi:10.1038/nrm3919
8. Flotho, A. and Melchior, F. (2013) Sumoylation: a regulatory protein modification in health and disease. Annu. Rev. Biochem. 82, 357-385 doi:10.1146/annurev-biochem-061909-093311
9. Heideker, J. and Wertz, I.E. (2015) DUBs, the regulation of cell identity and disease. Biochem. J. 465, 1-26 doi:10.1042/BJ20140496
10. Charan, R.A. and LaVoie, M.J. (2015) Pathologic and therapeutic implications for the cell biology of parkin. Mol. Cell. Neurosci. 66(Pt A), 62-71 doi:10.1016/j.mcn.2015.02.008
11. Roy, R., Chun, J. and Powell, S.N. (2011) BRCA1 and BRCA2: different roles in a common pathway of genome protection. Nat. Rev. Cancer 12, 68-78 doi:10.1038/nrc3181
12. Hatakeyama, S. (2011) TRIM proteins and cancer. Nat. Rev. Cancer 11, 792-804 doi:10.1038/nrc3139
13. van Wijk, S.J. and Timmers, HT. (2010) The family of ubiquitin-conjugating enzymes (E2s): deciding between life and death of proteins. FASEB J. 24, 981-993 doi:10.1096/fj.09-136259
14. Burroughs, A.M., Jaffee, M., Iyer, L.M. and Aravind, L. (2008) Anatomy of the E2 ligase fold: implications for enzymology and evolution of ubiquitin/Ublike protein conjugation. J. Struct. Biol. 162, 205-218 doi:10.1016/j.jsb.2007.12.006
15. Michelle, C, Vourc'h, P., Mignon, L. and Andres, CR. (2009) What was the set of ubiquitin and ubiquitin-like conjugating enzymes in the eukaryote common ancestor? J. Mol. Evol. 68, 616-628 doi:10.1007/s00239-009-9225-6
16. Berndsen, CE, Wiener, R., Yu, I.W., Ringel, A.E. and Wolberger, C. (2013) A conserved asparagine has a structural role in ubiquitin-conjugating enzymes. Nat. Chem. Biol. 9, 154-156 doi:10.1038/nchembio.1159
17. Cook, B.W. and Shaw, G.S. (2012) Architecture of the catalytic HPN motif is conserved in all E2 conjugating enzymes. Biochem. J. 445, 167-174 doi:10.1042/BJ20120504
18. Sheng, Y, Hong, J.H., Doherty, R., Srikumar, T, Shloush, J., Avvakumov, G.V. et al. (2012) A human ubiquitin conjugating enzyme (E2)-HECT E3 ligase structure-function screen. Mol. Cell Proteomics 11, 329-341 doi:10.1074/mcp.O111.013706
19. Plechanovová, A., Jaffray, E.G., Tatham, M.H., Naismith, J.H. and Hay, R.T (2012) Structure of a RING E3 ligase and ubiquitin-loaded E2 primed for catalysis. Nature 489, 115-120 doi:10.1038/nature11376
20. Sarcevic, B., Mawson, A., Baker, R.T. and Sutherland, R.L. (2002) Regulation of the ubiquitin-conjugating enzyme hHR6A by CDK-mediated phosphorylation. EMBO J. 21, 2009-2018 doi:10.1093/emboj/21.8.2009
21. Shchebet, A., Karpiuk, O., Kremmer, E., Eick, D. and Johnsen, S.A. (2012) Phosphorylation by cyclin-dependent kinase-9 controls ubiquitin-conjugating enzyme-2A function. Cell Cycle 11, 2122-2127 doi:10.4161/cc.20548
22. Valimberti, I., Tiberti, M., Lambrughi, M., Sarcevic, B. and Papaleo, E. (2015) E2 superfamily of ubiquitin-conjugating enzymes: constitutively active or activated through phosphorylation in the catalytic cleft. Sci. Rep. 5, 14849 doi:10.1038/srep14849
23. Wood, A., Schneider, J., Dover, J., Johnston, M. and Shilatifard, A. (2005) The Bur1/Bur2 complex is required for histone H2B monoubiquitination by Rad6/Bre1 and histone methylation by COMPASS. Mol. Cell 20, 589-599 doi:10.1016/j.molcel.2005.09.010
24. Chiu, Y.-H., Sun, Q. and Chen, Z.J. (2007) E1-L2 activates both ubiquitin and FAT10. Mol. Cell. 27, 1014-1023 doi:10.1016/j.molcel.2007.08.020
25. Jin, J., Li, X., Gygi, S.P. and Harper, J.W. (2007) Dual E1 activation systems for ubiquitin differentially regulate E2 enzyme charging. Nature 447, 1135-1138 doi:10.1038/nature05902
26. Pelzer, C, Kassner, I., Matentzoglu, K., Singh, R.K., Wollscheid, H.-P., Scheffner, M. et al. (2007) UBE1L2, a novel E1 enzyme specific for ubiquitin. J. Biol. Chem. 282, 23010-23014 doi:10.1074/jbc.C700111200
27. Schulman, B.A. and Harper, J.W. (2009) Ubiquitinlike protein activation by E1 enzymes: the apex for downstream signalling pathways. Nat. Rev. Mol. Cell Biol. 10, 319-331 doi:10.1038/nrm2673
28. Streich, Jr, FC and Lima, CD. (2014) Structural and functional insights to ubiquitin-like protein conjugation. Annu. Rev. Biophys. 43, 357-379 doi:10.1146/annurev-biophys-051013-022958
29. Hamilton, K.S., Ellison, M.J., Barber, K.R., Williams, R.S., Huzil, J.T., McKenna, S. et al. (2001) Structure of a conjugating enzyme-ubiquitin thiolester intermediate reveals a novel role for the ubiquitin tail. Structure 9, 897-904 doi:10.1016/S0969-2126(01)00657-8
30. Page, R.C., Pruneda, J.N., Amick, J., Klevit, R.E. and Misra, S. (2012) Structural insights into the conformation and oligomerization of E2-ubiquitin conjugates. Biochemistry 51, 4175-4187 doi:10.1021/bi300058m
31. Pruneda, J.N., Stoll, K.E., Bolton, L.J., Brzovic, P.S. and Klevit, R.E. (2011) Ubiquitin in motion: structural studies of the ubiquitin-conjugating enzyme approximately ubiquitin conjugate. Biochemistry 50, 1624-1633 doi:10.1021/bi101913m
32. Saha, A., Lewis, S., Kleiger, G., Kuhlman, B. and Deshaies, R.J. (2011) Essential role for ubiquitin-ubiquitin-conjugating enzyme interaction in ubiquitin discharge from Cdc34 to substrate. Mol. Cell 42, 75-83 doi:10.1016/j.molcel.2011.03.016
33. Wickliffe, K.E., Lorenz, S., Wemmer, D.E., Kuriyan, J. and Rape, M. (2011) The mechanism of linkage-specific ubiquitin chain elongation by a single-subunit E2. Cell 144, 769-781 doi:10.1016/j.cell.2011.01.035
34. Rodrigo-Brenni, M.C, Foster, S.A. and Morgan, D.O. (2010) Catalysis of lysine 48-specific ubiquitin chain assembly by residues in E2 and ubiquitin. Mol. Cell 39, 548-559 doi:10.1016/j.molcel.2010.07.027
35. Middleton, A.J. and Day, C.L. (2015) The molecular basis of lysine 48 ubiquitin chain synthesis by Ube2K. Sci. Rep. 5, 16793 doi:10.1038/srep16793
36. Lorenz, S., Bhattacharyya, M., Feiler, C., Rape, M. and Kuriyan, J. (2016) Crystal structure of a Ube2S-Ubiquitin conjugate. PLoS ONE 11, e0147550 doi:10.1371/journal.pone.0147550
37. Eddins, M.J., Carlile, C.M., Gomez, K.M., Pickart, C.M. and Wolberger, C. (2006) Mms2-Ubc13 covalently bound to ubiquitin reveals the structural basis of linkage-specific polyubiquitin chain formation. Nat. Struct. Mol. Biol. 13, 915-920 doi:10.1038/nsmb1148
38. Li, W., Tu, D., Brunger, A.T. and Ye, Y. (2007) A ubiquitin ligase transfers preformed polyubiquitin chains from a conjugating enzyme to a substrate. Nature 446, 333-337 doi:10.1038/nature05542
39. Ravid, T. and Hochstrasser, M. (2007) Autoregulation of an E2 enzyme by ubiquitin-chain assembly on its catalytic residue. Nat. Cell Biol. 9, 422-427 doi:10.1038/ncb1558
40. Liu, W., Shang, Y., Zeng, Y., Liu, C., Li, Y., Zhai, L. et al. (2014) Dimeric Ube2g2 simultaneously engages donor and acceptor ubiquitins to form Lys48-linked ubiquitin chains. EMBO J. 33, 46-61 doi:10.1002/embj.201385315
41. Petroski, M.D. and Deshaies, R.J. (2005) Mechanism of lysine 48-linked ubiquitin-chain synthesis by the cullin-RING ubiquitin-ligase complex SCF-Cdc34. Cell 123, 1107-1120 doi:10.1016/j.cell.2005.09.033
42. Chong, R.A., Wu, K., Spratt, D.E., Yang, Y., Lee, C., Nayak, J. et al. (2014) Pivotal role for the ubiquitin Y59-E51 loop in lysine 48 polyubiquitination. Proc. Natl Acad. Sci. USA 111, 8434-8439 doi:10.1073/pnas.1407849111
43. Ziemba, A., Hill, S., Sandoval, D., Webb, K., Bennett, E.J. and Kleiger, G. (2013) Multimodal mechanism of action for the Cdc34 acidic loop: a case study for why ubiquitin-conjugating enzymes have loops and tails. J. Biol. Chem. 288, 34882-34896 doi:10.1074/jbc.M113.509190
44. Stewart, M.D., Ritterhoff, T., Klevit, R.E. and Brzovic, P.S. (2016) E2 enzymes: more than just middle men. Cell Res. 26, 423-440 doi:10.1038/cr.2016.35
45. Windheim, M., Peggie, M. and Cohen, P. (2008) Two different classes of E2 ubiquitin-conjugating enzymes are required for the mono-ubiquitination of proteins and elongation by polyubiquitin chains with a specific topology. Biochem. J. 409, 723-729 doi:10.1042/BJ20071338
46. Parker, J.L. and Ulrich, H.D. (2009) Mechanistic analysis of PCNA poly-ubiquitylation by the ubiquitin protein ligases Rad18 and Rad5. EMBO J. 28, 3657-3666 doi:10.1038/emboj.2009.303
47. Rodrigo-Brenni, M.C. and Morgan, D.O. (2007) Sequential E2s drive polyubiquitin chain assembly on APC targets. Cell 130, 127-139 doi:10.1016/j.cell.2007.05.027
48. Schumacher, F.-R., Wilson, G. and Day, C.L. (2013) The N-terminal extension of UBE2E ubiquitin-conjugating enzymes limits chain assembly. J. Mol. Biol. 425, 4099-4111 doi:10.1016/j.jmb.2013.06.039
49. Sun, L. and Fang, J. (2016) E3-independent constitutive monoubiquitination complements histone methyltransferase activity of SETDB1. Mol. Cell 62, 958-966 doi:10.1016/j.molcel.2016.04.022
50. Nakada, S., Tai, I., Panier, S., Al-Hakim, A., Iemura, S.-I., Juang, Y.C. et al. (2010) Non-canonical inhibition of DNA damage-dependent ubiquitination by OTUB1. Nature 466, 941-946 doi:10.1038/nature09297
51. Wiener, R., DiBello, A.T., Lombardi, P.M., Guzzo, C.M., Zhang, X., Matunis, M.J. et al. (2013) E2 ubiquitin-conjugating enzymes regulate the deubiquitinating activity of OTUB1. Nat. Struct. Mol. Biol. 20, 1033-1039 doi:10.1038/nsmb.2655
52. Juang, Y.-C., Landry, M.-C., Sanches, M., Vittal, V., Leung, C.C.Y., Ceccarelli, D.F. et al. (2012) OTUB1 co-opts Lys48-linked ubiquitin recognition to suppress E2 enzyme function. Mol. Cell 45, 384-397 doi:10.1016/j.molcel.2012.01.011
53. Eletr, Z.M., Huang, D.T., Duda, D.M., Schulman, B.A. and Kuhlman, B. (2005) E2 conjugating enzymes must disengage from their E1 enzymes before E3-dependent ubiquitin and ubiquitin-like transfer. Nat. Struct. Mol. Biol. 12, 933-934 doi:10.1038/nsmb984
54. Huang, D.T., Paydar, A., Zhuang, M., Waddell, M.B., Holton, J.M. and Schulman, B.A. (2005) Structural basis for recruitment of Ubc12 by an E2 binding domain in NEDD8's E1. Mol. Cell. 17, 341-350 doi:10.1016/j.molcel.2004.12.020
55. Benirschke, R.C., Thompson, J.R., Nominé, Y., Wasielewski, E., Juranic, N., Macura, S. et al. (2010) Molecular basis for the association of human E4B U box ubiquitin ligase with E2-conjugating enzymes UbcH5c and Ubc4. Structure 18, 955-965 doi:10.1016/j.str.2010.04.017
56. Xu, Z., Kohli, E., Devlin, K.I., Bold, M., Nix, J.C. and Misra, S. (2008) Interactions between the quality control ubiquitin ligase CHIP and ubiquitin conjugating enzymes. BMC Struct. Biol. 8, 26 doi:10.1186/1472-6807-8-26
57. Mace, P.D., Linke, K., Feltham, R., Schumacher, F.-R., Smith, C.A., Vaux, D.L. et al. (2008) Structures of the cIAP2 RING domain reveal conformational changes associated with ubiquitin-conjugating enzyme (E2) recruitment. J. Biol. Chem. 283, 31633-31640 doi:10.1074/jbc.M804753200
58. Metzger, M.B., Pruneda, J.N., Klevit, R.E. and Weissman, A.M. (2014) RING-type E3 ligases: master manipulators of E2 ubiquitin-conjugating enzymes and ubiquitination. Biochim. Biophys. Acta 1843, 47-60 doi:10.1016/j.bbamcr.2013.05.026
59. Scheffner, M. and Kumar, S. (2014) Mammalian HECT ubiquitin-protein ligases: biological and pathophysiological aspects. Biochim. Biophys. Acta 1843, 61-74 doi:10.1016/j.bbamcr.2013.03.024
60. Spratt, D.E., Walden, H. and Shaw, G.S. (2014) RBR e3 ubiquitin ligases: new structures, new insights, new questions. Biochem. J. 458, 421-437 doi:10.1042/BJ20140006
61. Kamadurai, H.B., Souphron, J., Scott, D.C., Duda, D.M., Miller, D.J., Stringer, D. et al. (2009) Insights into ubiquitin transfer cascades from a structure of a UbcH5B approximately ubiquitin-HECT(NEDD4L) complex. Mol. Cell 36, 1095-1102 doi:10.1016/j.molcel.2009.11.010
62. Pruneda, J.N., Littlefield, P.J., Soss, S.E., Nordquist, K.A., Chazin, W.J., Brzovic, P.S. et al. (2012) Structure of an E3:E2-Ub Complex Reveals an Allosteric Mechanism Shared among RING/U-box Ligases. Mol. Cell 47, 933-942 doi:10.1016/j.molcel.2012.07.001
63. Lechtenberg, B.C., Rajput, A., Sanishvili, R., Dobaczewska, M.K., Ware, C.F., Mace, P.D. et al. (2016) Structure of a HOIP/E2-ubiquitin complex reveals RBR E3 ligase mechanism and regulation. Nature 529, 546-550 doi:10.1038/nature16511
64. Dove, K.K., Stieglitz, B., Duncan, E.D., Rittinger, K. and Klevit, R.E. (2016) Molecular insights into RBR E3 ligase ubiquitin transfer mechanisms. EMBO Rep 17, 1221-1235 doi:10.15252/embr.201642641
65. Dou, H., Buetow, L., Sibbet, G.J., Cameron, K. and Huang, D.T. (2012) BIRC7-E2 ubiquitin conjugate structure reveals the mechanism of ubiquitin transfer by a RING dimer. Nat. Struct. Mol. Biol. 19, 876-883 doi:10.1038/nsmb.2379
66. Dou, H., Buetow, L., Sibbet, G.J., Cameron, K. and Huang, D.T. (2013) Essentiality of a non-RING element in priming donor ubiquitin for catalysis by a monomeric E3. Nat. Struct. Mol. Biol. 20, 982-986 doi:10.1038/nsmb.2621
67. McGinty, R.K., Henrici, R.C. and Tan, S. (2014) Crystal structure of the PRC1 ubiquitylation module bound to the nucleosome. Nature 514, 591-596 doi:10.1038/nature13890
68. Brzovic, P.S., Lissounov, A., Christensen, D.E., Hoyt, D.W. and Klevit, R.E. (2006) A UbcH5/ubiquitin noncovalent complex is required for processive BRCA1-directed ubiquitination. Mol. Cell 21, 873-880 doi:10.1016/j.molcel.2006.02.008
69. Buetow, L., Gabrielsen, M., Anthony, N.G., Dou, H., Patel, A., Aitkenhead, H. et al. (2015) Activation of a primed RING E3-E2-ubiquitin complex by non-covalent ubiquitin. Mol. Cell 58, 297-310 doi:10.1016/j.molcel.2015.02.017
70. Das, R., Mariano, J., Tsai, Y.C., Kalathur, R.C., Kostova, Z., Li, J. et al. (2009) Allosteric activation of E2-RING finger-mediated ubiquitylation by a structurally defined specific E2-binding region of gp78. Mol. Cell 34, 674-685 doi:10.1016/j.molcel.2009.05.010
71. Li, W., Tu, D., Li, L., Wollert, T., Ghirlando, R., Brunger, A.T. et al. (2009) Mechanistic insights into active site-associated polyubiquitination by the ubiquitin-conjugating enzyme Ube2g2. Proc. Natl Acad. Sci. USA 106, 3722-3727 doi:10.1073/pnas.0808564106
72. Das, R., Liang, Y.-H., Mariano, J., Li, J., Huang, T., King, A. et al. (2013) Allosteric regulation of E2:E3 interactions promote a processive ubiquitination machine. EMBO J. 32, 2504-2516 doi:10.1038/emboj.2013.174
73. Metzger, M.B., Liang, Y.-H., Das, R., Mariano, J., Li, S., Li, J. et al. (2013) A structurally unique E2-binding domain activates ubiquitination by the ERAD E2, Ubc7p, through multiple mechanisms. Mol. Cell 50, 516-527 doi:10.1016/j.molcel.2013.04.004
74. Li, S., Liang, Y.H., Mariano, J., Metzger, M.B., Stringer, D.K., Hristova, V.A. et al. (2015) Insights into ubiquitination from the unique clamp-like binding of the RING E3 AO7 to the E2 UbcH5B. J. Biol. Chemistry 290, 30225-30239 doi:10.1074/jbc.M115.685867
75. Hibbert, R.G., Huang, A., Boelens, R. and Sixma, T.K. (2011) E3 ligase Rad18 promotes monoubiquitination rather than ubiquitin chain formation by E2 enzyme Rad6. Proc. Natl Acad. Sci. USA 108, 5590-5595 doi:10.1073/pnas.1017516108
76. Turco, E., Gallego, L.D., Schneider, M. and Köhler, A. (2015) Monoubiquitination of histone H2B is intrinsic to the Bre1 RING domain-Rad6 interaction and augmented by a second Rad6-binding site on Bre1. J. Biol. Chem. 290, 5298-5310 doi:10.1074/jbc.M114.626788
77. Lobitz, S. and Velleuer, E. (2006) Guido Fanconi (1892-1979): a jack of all trades. Nat. Rev. Cancer 6, 893-898 doi:10.1038/nrc2009
78. Langevin, F., Crossan, G.P., Rosado, I.V., Arends, M.J. and Patel, K.J. (2011) Fancd2 counteracts the toxic effects of naturally produced aldehydes in mice. Nature 475, 53-58 doi:10.1038/nature10192
79. Rosado, I.V., Langevin, F., Crossan, G.P., Takata, M. and Patel, K.J. (2011) Formaldehyde catabolism is essential in cells deficient for the Fanconi anemia DNA-repair pathway. Nat. Struct. Mol. Biol. 18, 1432-1434 doi:10.1038/nsmb.2173
80. Pontel, L.B., Rosado, I.V., Burgos-Barragan, G., Garaycoechea, J.I., Yu, R., Arends, M.J. et al. (2015) Endogenous formaldehyde is a hematopoietic stem cell genotoxin and metabolic carcinogen. Mol. Cell 60, 177-188 doi:10.1016/j.molcel.2015.08.020
81. Garaycoechea, J.I., Crossan, G.P., Langevin, F., Daly, M., Arends, M.J. and Patel, K.J. (2012) Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function. Nature 489, 571-575 doi:10.1038/nature11368
82. Bogliolo, M. and Surrallés, J. (2015) Fanconi anemia: a model disease for studies on human genetics and advanced therapeutics. Curr. Opin. Genet. Dev. 33, 32-40 doi:10.1016/j.gde.2015.07.002
83. Duxin, J.P. and Walter, J.C. (2015) What is the DNA repair defect underlying Fanconi anemia? Curr. Opin. Cell Biol. 37, 49-60 doi:10.1016/j.ceb.2015.09.002
84. Lopez-Martinez, D., Liang, C.-C. and Cohn, M.A. (2016) Cellular response to DNA interstrand crosslinks: the Fanconi anemia pathway. Cell. Mol. Life Sci. 73, 3097-3114 doi:10.1007/s00018-016-2218-x
85. Ceccaldi, R., Sarangi, P. and D'Andrea, A.D. (2016) The Fanconi anaemia pathway: new players and new functions. Nat. Rev. Mol. Cell Biol. 17, 337-349 doi:10.1038/nrm.2016.48
86. Garcia-Higuera, I., Taniguchi, T., Ganesan, S., Meyn, M.S., Timmers, C., Hejna, J. et al. (2001) Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell 7, 249-262 doi:10.1016/S1097-2765(01)00173-3
87. Smogorzewska, A., Matsuoka, S., Vinciguerra, P., McDonald, III, E.R., Hurov, K.E., Luo, J. et al. (2007) Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell 129, 289-301 doi:10.1016/j.cell.2007.03.009
88. Sims, A.E., Spiteri, E., Sims, III, R.J., Arita, A.G., Lach, F.P., Landers, T. et al. (2007) FANCI is a second monoubiquitinated member of the Fanconi anemia pathway. Nat. Struct. Mol. Biol. 14, 564-567 doi:10.1038/nsmb1252
89. Dorsman, J.C., Levitus, M., Rockx, D., Rooimans, M.A., Oostra, A.B., Haitjema, A. et al. (2007) Identification of the Fanconi anemia complementation group I gene, FANCI. Cell. Oncol. 29, 211-218 PMID:17452773
90. Meetei, A.R., Sechi, S., Wallisch, M., Yang, D., Young, M.K., Joenje, H. et al. (2003) A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome. Mol. Cell. Biol. 23, 3417-3426 doi:10.1128/MCB.23.10.3417-3426.2003
91. Ling, C., Ishiai, M., Ali, A.M., Medhurst, A.L., Neveling, K., Kalb, R. et al. (2007) FAAP100 is essential for activation of the Fanconi anemia-associated DNA damage response pathway. EMBO J. 26, 2104-2114 doi:10.1038/sj.emboj.7601666
92. Ali, A.M., Pradhan, A., Singh, T.R., Du, C., Li, J., Wahengbam, K. et al. (2012) FAAP20: a novel ubiquitin-binding FA nuclear core-complex protein required for functional integrity of the FA-BRCA DNA repair pathway. Blood 119, 3285-3294 doi:10.1182/blood-2011-10-385963
93. Meetei, A.R., de Winter, J.P., Medhurst, A.L., Wallisch, M., Waisfisz, Q., van de Vrugt, H.J. et al. (2003) A novel ubiquitin ligase is deficient in Fanconi anemia. Nat. Genet. 35, 165-170 doi:10.1038/ng1241
94. Meetei, A.R., Medhurst, A.L., Ling, C., Xue, Y., Singh, T.R., Bier, P. et al. (2005) A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M. Nat. Genet. 37, 958-963 doi:10.1038/ng1626
95. Mosedale, G., Niedzwiedz, W., Alpi, A., Perrina, F., Pereira-Leal, J.B., Johnson, M. et al. (2005) The vertebrate Hef ortholog is a component of the Fanconi anemia tumor-suppressor pathway. Nat. Struct. Mol. Biol. 12, 763-771 doi:10.1038/nsmb981
96. Ciccia, A., Ling, C., Coulthard, R., Yan, Z., Xue, Y., Meetei, A.R. et al. (2007) Identification of FAAP24, a Fanconi anemia core complex protein that interacts with FANCM. Mol. Cell 25, 331-343 doi:10.1016/j.molcel.2007.01.003
97. Singh, T.R., Saro, D., Ali, A.M., Zheng, X.-F., Du, C.-H., Killen, M.W. et al. (2010) MHF1-MHF2, a histone-fold-containing protein complex, participates in the Fanconi anemia pathway via FANCM. Mol. Cell 37, 879-886 doi:10.1016/j.molcel.2010.01.036
98. Yan, Z., Delannoy, M., Ling, C., Daee, D., Osman, F., Muniandy, P.A. et al. (2010) A histone-fold complex and FANCM form a conserved DNA-remodeling complex to maintain genome stability. Mol. Cell 37, 865-878 doi:10.1016/j.molcel.2010.01.039
99. Alpi, A., Langevin, F., Mosedale, G., Machida, Y.J., Dutta, A. and Patel, K.J. (2007) UBE2T, the Fanconi anemia core complex, and FANCD2 are recruited independently to chromatin: a basis for the regulation of FANCD2 monoubiquitination. Mol. Cell Biol. 27, 8421-8430 doi:10.1128/MCB.00504-07
100. Alpi, A.F., Pace, P.E., Babu, M.M. and Patel, K.J. (2008) Mechanistic insight into site-restricted monoubiquitination of FANCD2 by Ube2t, FANCL, and FANCI. Mol. Cell 32, 767-777 doi:10.1016/j.molcel.2008.12.003
101. Rajendra, E., Oestergaard, V.H., Langevin, F., Wang, M., Dornan, G.L., Patel, K.J. et al. (2014) The genetic and biochemical basis of FANCD2 monoubiquitination. Mol. Cell 54, 858-869 doi:10.1016/j.molcel.2014.05.001
102. Cole, A.R., Lewis, L.P.C. and Walden, H. (2010) The structure of the catalytic subunit FANCL of the Fanconi anemia core complex. Nat. Struct. Mol. Biol. 17, 294-298 doi:10.1038/nsmb.1759
103. Hodson, C., Cole, A.R., Lewis, L.P.C., Miles, J.A., Purkiss, A. and Walden, H. (2011) Structural analysis of human FANCL, the E3 ligase in the Fanconi anemia pathway. J. Biol. Chem. 286, 32628-32637 doi:10.1074/jbc.M111.244632
104. Machida, Y.J., Machida, Y., Chen, Y., Gurtan, A.M., Kupfer, G.M., D'Andrea, A.D. et al. (2006) UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation. Mol. Cell 23, 589-596 doi:10.1016/j.molcel.2006.06.024
105. Hodson, C., Purkiss, A., Miles, J.A. and Walden, H. (2014) Structure of the human FANCL RING-Ube2T complex reveals determinants of cognate E3-E2 selection. Structure 22, 337-344 doi:10.1016/j.str.2013.12.004
106. Kar, G., Keskin, O., Nussinov, R. and Gursoy, A. (2012) Human proteome-scale structural modeling of E2-E3 interactions exploiting interface motifs. J. Proteome Res. 11, 1196-1207 doi:10.1021/pr2009143
107. Markson, G., Kiel, C., Hyde, R., Brown, S., Charalabous, P., Bremm, A. et al. (2009) Analysis of the human E2 ubiquitin conjugating enzyme protein interaction network. Genome Res. 19, 1905-1911 doi:10.1101/gr.093963.109
108. van Wijk, S.J., de Vries, S.J., Kemmeren, P., Huang, A., Boelens, R., Bonvin, A.M. et al. (2009) A comprehensive framework of E2-RING E3 interactions of the human ubiquitin-proteasome system. Mol. Syst. Biol. 5, 295 doi:10.1038/msb.2009.76
109. Kelsall, I.R., Duda, D.M., Olszewski, J.L., Hofmann, K., Knebel, A., Langevin, F. et al. (2013) TRIAD1 and HHARI bind to and are activated by distinct neddylated Cullin-RING ligase complexes. EMBO J. 32, 2848-2860 doi:10.1038/emboj.2013.209
110. Tatham, M.H., Plechanovová, A., Jaffray, E.G. Salmen, H. and Hay, R.T. (2013) Ube2w conjugates ubiquitin to alpha-amino groups of protein N-termini. Biochem. J. 453, 137-145 doi:10.1042/BJ20130244
111. Christensen, D.E., Brzovic, P.S. and Klevit, R.E. (2007) E2-BRCA1 RING interactions dictate synthesis of mono-or specific polyubiquitin chain linkages. Nat. Struct. Mol. Biol. 14, 941-948 doi:10.1038/nsmb1295
112. Christensen, D.E. and Klevit, R.E. (2009) Dynamic interactions of proteins in complex networks: identifying the complete set of interacting E2s for functional investigation of E3-dependent protein ubiquitination. FEBS J. 276, 5381-5389 doi:10.1111/j.1742-4658.2009.07249.x
113. Ueki, T., Park, J.-H., Nishidate, T., Kijima, K., Hirata, K., Nakamura, Y. et al. (2009) Ubiquitination and downregulation of BRCA1 by ubiquitin-conjugating enzyme E2T overexpression in human breast cancer cells. Cancer Res. 69, 8752-8760 doi:10.1158/0008-5472.CAN-09-1809
114. Hira, A., Yoshida, K., Sato, K., Okuno, Y., Shiraishi, Y., Chiba, K. et al. (2015) Mutations in the gene encoding the E2 conjugating enzyme UBE2T cause Fanconi anemia. Am. J. Hum. Genet. 96, 1001-1007 doi:10.1016/j.ajhg.2015.04.022
115. Rickman, K.A., Lach, F.P., Abhyankar, A., Donovan, F.X., Sanborn, E.M., Kennedy, J.A. et al. (2015) Deficiency of UBE2T, the E2 ubiquitin ligase necessary for FANCD2 and FANCI ubiquitination, causes FA-T subtype of Fanconi anemia. Cell. Rep. 12, 35-41 doi:10.1016/j.celrep.2015.06.014
116. Virts, E.L., Jankowska, A., Mackay, C., Glaas, M.F., Wiek, C., Kelich, S.L. et al. (2015) AluY-mediated germline deletion, duplication and somatic stem cell reversion in UBE2T defines a new subtype of Fanconi anemia. Hum. Mol. Genet. 24, 5093-5108 doi:10.1093/hmg/ddv227
117. Kelsall, I.R., Langenick, J., Mackay, C., Patel, K.J. and Alpi, A.F. (2012) The Fanconi anaemia components UBE2T and FANCM are functionally linked to nucleotide excision repair. PLoS ONE 7, e36970 doi:10.1371/journal.pone.0036970
118. Zhang, Y., Zhou, X., Zhao, L., Li, C., Zhu, H., Xu, L. et al. (2011) UBE2W interacts with FANCL and regulates the monoubiquitination of Fanconi anemia protein FANCD2. Mol. Cells 31, 113-122 doi:10.1007/s10059-011-0015-9
119. Vittal, V., Shi, L., Wenzel, D.M., Scaglione, K.M., Duncan, E.D., Basrur, V. et al. (2014) Intrinsic disorder drives N-terminal ubiquitination by Ube2w. Nat. Chem. Biol. 11, 83-89 doi:10.1038/nchembio.1700
120. Wang, B., Merillat, S.A., Vincent, M., Huber, A.K., Basrur, V., Mangelberger, D. et al. (2016) Loss of the ubiquitin-conjugating enzyme UBE2W results in susceptibility to early postnatal lethality and defects in skin, immune, and Male reproductive systems. J. Biol. Chem. 291, 3030-3042 doi:10.1074/jbc.M115.676601
121. Maure, J.F., Moser, S.C., Jaffray, E.G., Alpi, A.F. and Hay, R.T. (2016) Loss of ubiquitin E2 Ube2w rescues hypersensitivity of Rnf4 mutant cells to DNA damage. Sci. Rep. 6, 26178 doi:10.1038/srep26178
122. Yin, Y., Seifert, A., Chua, J.S., Maure, J.-F., Golebiowski, F. and Hay, R.T. (2012) SUMO-targeted ubiquitin E3 ligase RNF4 is required for the response of human cells to DNA damage. Genes Dev. 26, 1196-1208 doi:10.1101/gad.189274.112
123. Galanty, Y., Belotserkovskaya, R., Coates, J. and Jackson, S.P. (2012) RNF4, a SUMO-targeted ubiquitin E3 ligase, promotes DNA double-strand break repair. Genes Dev. 26, 1179-1195 doi:10.1101/gad.188284.112
124. Alter, B.P. (2014) Fanconi anemia and the development of leukemia. Best. Pract. Res. Clin. Haematol. 27, 214-221 doi:10.1016/j.beha.2014.10.002
125. Wooster, R., Neuhausen, S.L., Mangion, J., Quirk, Y., Ford, D., Collins, N. et al. (1994) Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265, 2088-2090 doi:10.1126/science.8091231
126. Rahman, N., Seal, S., Thompson, D., Kelly, P., Renwick, A., Elliott, A. et al. (2007) PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat. Genet. 39, 165-167 doi:10.1038/ng1959
127. Cantor, S.B., Bell, D.W., Ganesan, S., Kass, E.M., Drapkin, R., Grossman, S. et al. (2001) BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell 105, 149-160 doi:10.1016/S0092-8674(01)00304-X
128. Loveday, C., Turnbull, C., Ruark, E., Xicola, R.M., Ramsay, E., Hughes, D. et al. (2012) Germline RAD51C mutations confer susceptibility to ovarian cancer. Nat. Genet. 44, 475-476; author reply 6 doi:10.1038/ng.2224
129. Meindl, A., Hellebrand, H., Wiek, C., Erven, V., Wappenschmidt, B., Niederacher, D. et al. (2010) Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat. Genet. 42, 410-414 doi:10.1038/ng.569
130. Gao, J., Aksoy, B.A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S.O. et al. (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 6, Pl1 doi:10.1126/scisignal.2004088
131. Corson, T.W., Huang, A., Tsao, M.-S. and Gallie, B.L. (2005) KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers. Oncogene 24, 4741-4753 doi:10.1038/sj.onc.1208641
132. Hao, J., Xu, A., Xie, X., Hao, J., Tian, T., Gao, S. et al. (2008) Elevated expression of UBE2T in lung cancer tumors and cell lines. Tumour Biol. 29, 195-203 doi:10.1159/000148187
133. Wen, M., Kwon, Y., Wang, Y., Mao, J.-H. and Wei, G. (2015) Elevated expression of UBE2T exhibits oncogenic properties in human prostate cancer. Oncotarget 6, 25226-25239 doi:10.18632/oncotarget.4712
134. Hu, W., Xiao, L., Cao, C., Hua, S. and Wu, D. (2016) UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3beta/beta-catenin pathway. Oncotarget 7, 15161-15172 PMID:26943030
135. Yu, H., Xiang, P., Pan, Q., Huang, Y., Xie, N. and Zhu, W. (2016) Ubiquitin-conjugating enzyme E2T is an independent prognostic factor and promotes gastric cancer progression. Tumour. Biol 1-10 doi:10.1007/s13277-016-5020-3
136. Clague, M.J., Heride, C. and Urbé, S. (2015) The demographics of the ubiquitin system. Trends Cell Biol. 25, 417-426 doi:10.1016/j.tcb.2015.03.002
137. Lewis, M.J., Vyse, S., Shields, A.M., Boeltz, S., Gordon, P.A., Spector, T.D. et al. (2015) UBE2L3 polymorphism amplifies NF-κB activation and promotes plasma cell development, linking linear ubiquitination to multiple autoimmune diseases. Am. J. Hum. Genet. 96, 221-234 doi:10.1016/j.ajhg.2014.12.024
138. Han, J.-W., Zheng, H.-F., Cui, Y., Sun, L.-D., Ye, D.-Q., Hu, Z. et al. (2009) Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat. Genet. 41, 1234-1237 doi:10.1038/ng.472
139. Gateva, V., Sandling, J.K., Hom, G., Taylor, K.E., Chung, S.A., Sun, X. et al. (2009) A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat. Genet. 41, 1228-1233 doi:10.1038/ng.468
140. Wang, S., Adrianto, I., Wiley, G.B., Lessard, C.J., Kelly, J.A., Adler, A.J. et al. (2012) A functional haplotype of UBE2L3 confers risk for systemic lupus erythematosus. Genes Immun. 13, 380-387 doi:10.1038/gene.2012.6
141. Jostins, L., Ripke, S., Weersma, R.K., Duerr, R.H., McGovern, D.P., Hui, K.Y. et al. (2012) Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119-124 doi:10.1038/nature11582
142. Franke, A., McGovern, D.P., Barrett, J.C., Wang, K., Radford-Smith, G.L., Ahmad, T. et al. (2010) Genomewide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat. Genet. 42, 1118-1125 doi:10.1038/ng.717
143. Stahl, E.A., Raychaudhuri, S., Remmers, E.F., Xie, G., Eyre, S., Thomson, B.P. et al. (2010) Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat. Genet. 42, 508-514 doi:10.1038/ng.582
144. Dubois, P.C., Trynka, G., Franke, L., Hunt, K.A., Romanos, J., Curtotti, A. et al. (2010) Multiple common variants for celiac disease influencing immune gene expression. Nat. Genet. 42, 295-302 doi:10.1038/ng.543
145. Tsoi, L.C., Spain, S.L., Knight, J., Ellinghaus, E., Stuart, P.E., Capon, F. et al. (2012) Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat. Genet. 44, 1341-1348 doi:10.1038/ng.2467
146. Hasebe, N., Kawasaki, A., Ito, I., Kawamoto, M., Hasegawa, M., Fujimoto, M. et al. (2012) Association of UBE2L3 polymorphisms with diffuse cutaneous systemic sclerosis in a Japanese population. Ann. Rheum. Dis. 71, 1259-1260 doi:10.1136/annrheumdis-2011-201091
147. Hinks, A., Cobb, J., Marion, M.C., Prahalad, S., Sudman, M., Bowes, J. et al. (2013) Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis. Nat. Genet. 45, 664-669 doi:10.1038/ng.2614
148. Orozco, G., Eyre, S., Hinks, A., Bowes, J., Morgan, A.W., Wilson, A.G. et al. (2011) Study of the common genetic background for rheumatoid arthritis and systemic lupus erythematosus. Ann. Rheum. Dis. 70, 463-468 doi:10.1136/ard.2010.137174
149. Huang, L., Kinnucan, E., Wang, G., Beaudenon, S., Howley, P.M., Huibregtse, J.M. et al. (1999) Structure of an E6AP-UbcH7 complex: insights into ubiquitination by the E2-E3 enzyme cascade. Science 286, 1321-1326 doi:10.1126/science.286.5443.1321
150. Kumar, S., Kao, W.H. and Howley, P.M. (1997) Physical interaction between specific E2 and Hect E3 enzymes determines functional cooperativity. J. Biol. Chem. 272, 13548-13554 doi:10.1074/jbc.272.21.13548
151. Nuber, U. and Scheffner, M. (1999) Identification of determinants in E2 ubiquitin-conjugating enzymes required for hect E3 ubiquitin-protein ligase interaction. J. Biol. Chem. 274, 7576-7582 doi:10.1074/jbc.274.11.7576
152. Wenzel, D.M., Lissounov, A., Brzovic, P.S. and Klevit, R.E. (2011) UBCH7 reactivity profile reveals parkin and HHARI to be RING/HECT hybrids. Nature 474, 105-108 doi:10.1038/nature09966
153. Eletr, Z.M. and Kuhlman, B. (2007) Sequence determinants of E2-E6AP binding affinity and specificity. J. Mol. Biol. 369, 419-428 doi:10.1016/j.jmb.2007.03.026
154. Grishin, A.M., Condos, T.E., Barber, K.R., Campbell-Valois, F.X., Parsot, C., Shaw, G.S. et al. (2014) Structural basis for the inhibition of host protein ubiquitination by Shigella effector kinase Ospg. Structure 22, 878-888 doi:10.1016/j.str.2014.04.010
155. Kim, D.W., Lenzen, G., Page, A.-L., Legrain, P., Sansonetti, P.J. and Parsot, C. (2005) The Shigella flexneri effector Ospg interferes with innate immune responses by targeting ubiquitin-conjugating enzymes. Proc. Natl Acad. Sci. USA 102, 14046-14051 doi:10.1073/pnas.0504466102
156. Duda, D.M., Olszewski, J.L., Schuermann, J.P., Kurinov, I., Miller, D.J., Nourse, A. et al. (2013) Structure of HHARI, a RING-IBR-RING ubiquitin ligase: autoinhibition of an Ariadne-family E3 and insights into ligation mechanism. Structure 21, 1030-1041 doi:10.1016/j.str.2013.04.019
157. Kumar, A., Aguirre, J.D., Condos, T.E., Martinez-Torres, R.J., Chaugule, V.K., Toth, R. et al. (2015) Disruption of the autoinhibited state primes the E3 ligase parkin for activation and catalysis. EMBO J. 34, 2506-2521 doi:10.15252/embj.201592337
158. Ronchi, V.P., Klein, J.M. and Haas, A.L. (2013) E6AP/UBE3A ubiquitin ligase harbors two E2 ubiquitin binding sites. J. Biol. Chem. 288, 10349-10360 doi:10.1074/jbc.M113.458059
159. Kirisako, T., Kamei, K., Murata, S., Kato, M., Fukumoto, H., Kanie, M. et al. (2006) A ubiquitin ligase complex assembles linear polyubiquitin chains. EMBO J. 25, 4877-4887 doi:10.1038/sj.emboj.7601360
160. Stieglitz, B., Morris-Davies, A.C., Koliopoulos, M.G., Christodoulou, E. and Rittinger, K. (2012) LUBAC synthesizes linear ubiquitin chains via a thioester intermediate. EMBO Rep. 13, 840-846 doi:10.1038/embor.2012.105
161. Rickard, J.A., Anderton, H., Etemadi, N., Nachbur, U., Darding, M., Peltzer, N. et al. (2014) TNFR1-dependent cell death drives inflammation in Sharpin-deficient mice. eLife 3 doi:10.7554/eLife.03464
162. Kumari, S., Redouane, Y., Lopez-Mosqueda, J., Shiraishi, R., Romanowska, M., Lutzmayer, S. et al. (2014) Sharpin prevents skin inflammation by inhibiting TNFR1-induced keratinocyte apoptosis. eLife 3 doi:10.7554/eLife.03422
163. Peltzer, N., Rieser, E., Taraborrelli, L., Draber, P., Darding, M., Pernaute, B. et al. (2014) HOIP deficiency causes embryonic lethality by aberrant TNFR1-mediated endothelial cell death. Cell Rep. 9, 153-165 doi:10.1016/j.celrep.2014.08.066
164. Mackay, C., Carroll, E., Ibrahim, A.F., Garg, A., Inman, G.J., Hay, R.T. et al. (2014) E3 ubiquitin ligase HOIP attenuates apoptotic cell death induced by cisplatin. Cancer Res. 74, 2246-2257 doi:10.1158/0008-5472.CAN-13-2131
165. Boisson, B., Laplantine, E., Prando, C., Giliani, S., Israelsson, E., Xu, Z. et al. (2012) Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency. Nat. Immunol. 13, 1178-1186 doi:10.1038/ni.2457
166. Boisson, B., Laplantine, E., Dobbs, K., Cobat, A., Tarantino, N., Hazen, M. et al. (2015) Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia. J. Exp. Med. 212, 939-951 doi:10.1084/jem.20141130
167. Ikeda, F., Deribe, Y.L., Skanland, S.S., Stieglitz, B., Grabbe, C., Franz-Wachtel, M. et al. (2011) SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis. Nature 471, 637-641 doi:10.1038/nature09814
168. Tokunaga, F., Nakagawa, T., Nakahara, M., Saeki, Y., Taniguchi, M., Sakata, S. et al. (2011) SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex. Nature 471, 633-636 doi:10.1038/nature09815
169. Gerlach, B., Cordier, S.M., Schmukle, A.C., Emmerich, C.H., Rieser, E., Haas, T.L. et al. (2011) Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 471, 591-596 doi:10.1038/nature09816
170. Perkins, N.D. (2012) The diverse and complex roles of NF-κB subunits in cancer. Nat. Rev. Cancer 12, 121-132 doi:10.1038/nrc3204
171. Yang, Y., Schmitz, R., Mitala, J., Whiting, A., Xiao, W., Ceribelli, M. et al. (2014) Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphisms. Cancer Discov. 4, 480-493 doi:10.1158/2159-8290.CD-13-0915
172. Dawson, T.M. and Dawson, V.L. (2010) The role of parkin in familial and sporadic Parkinson's disease. Mov. Disord. 25(Suppl 1), S32-S39 doi:10.1002/mds.22798
173. Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S. et al. (1998) Mutations in the parkin gene cause autosomal recessive juvenile Parkinsonism. Nature 392, 605-608 doi:10.1038/33416
174. Devine, M.J., Plun-Favreau, H. and Wood, N.W. (2011) Parkinson's disease and cancer: two wars, one front. Nat. Rev. Cancer 11, 812-823 doi:10.1038/nrc3150
175. Chaugule, V.K., Burchell, L., Barber, K.R., Sidhu, A., Leslie, S.J., Shaw, G.S. et al. (2011) Autoregulation of Parkin activity through its ubiquitin-like domain. EMBO J. 30, 2853-2867 doi:10.1038/emboj.2011.204
176. Spratt, D.E., Julio Martinez-Torres, R., Noh, Y.J., Mercier, P., Manczyk, N., Barber, K.R. et al. (2013) A molecular explanation for the recessive nature of parkin-linked Parkinson's disease. Nat. Commun. 4, 1983 doi:10.1038/ncomms2983
177. Trempe, J.F., Sauve, V., Grenier, K., Seirafi, M., Tang, M.Y., Menade, M. et al. (2013) Structure of Parkin reveals mechanisms for ubiquitin ligase activation. Science 340, 1451-1455 doi:10.1126/science.1237908
178. Wauer, T. and Komander, D. (2013) Structure of the human Parkin ligase domain in an autoinhibited state. EMBO J. 32, 2099-112 doi:10.1038/emboj.2013.125
179. Kondapalli, C., Kazlauskaite, A., Zhang, N., Woodroof, H.I., Campbell, D.G., Gourlay, R. et al. (2012) PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating serine 65. Open Biol. 2, 120080 doi:10.1098/rsob.120080
180. Iguchi, M., Kujuro, Y., Okatsu, K., Koyano, F., Kosako, H., Kimura, M. et al. (2013) Parkincatalyzed ubiquitin-ester transfer is triggered by PINK1-dependent phosphorylation. J. Biol. Chem. 288, 22019-22032 doi:10.1074/jbc.M113.467530
181. Kane, L.A., Lazarou, M., Fogel, A.I., Li, Y., Yamano, K., Sarraf, S.A. et al. (2014) PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity. J. Cell Biol. 205, 143-153 doi:10.1083/jcb.201402104
182. Kazlauskaite, A., Kondapalli, C., Gourlay, R., Campbell, D.G., Ritorto, M.S., Hofmann, K. et al. (2014) Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65. Biochem. J. 460, 127-141 doi:10.1042/BJ20140334
183. Koyano, F., Okatsu, K., Kosako, H., Tamura, Y., Go, E., Kimura, M. et al. (2014) Ubiquitin is phosphorylated by PINK1 to activate parkin. Nature 510, 162-166 doi:10.1038/nature13392
184. Geisler, S., Vollmer, S., Golombek, S. and Kahle, P.J. (2014) The ubiquitin-conjugating enzymes UBE2N, UBE2L3 and UBE2D2/3 are essential for Parkin-dependent mitophagy. J. Cell. Sci. 127(Pt 15), 3280-3293 doi:10.1242/jcs.146035
185. Fiesel, F.C., Moussaud-Lamodiere, E.L., Ando, M. and Springer, W. (2014) A specific subset of E2 ubiquitin-conjugating enzymes regulate Parkin activation and mitophagy differently. J. Cell Sci. 127(Pt 16), 3488-3504 doi:10.1242/jcs.147520
186. Wang, M., Suzuki, T., Kitada, T., Asakawa, S., Minoshima, S., Shimizu, N. et al. (2001) Developmental changes in the expression of parkin and UbcR7, a parkin-interacting and ubiquitin-conjugating enzyme, in rat brain. J. Neurochem. 77, 1561-1568 doi:10.1046/j.1471-4159.2001.00372.x
187. Nascimento, R.M., Otto, P.A., de Brouwer, A.P. and Vianna-Morgante, A.M. (2006) UBE2A, which encodes a ubiquitin-conjugating enzyme, is mutated in a novel X-linked mental retardation syndrome. Am. J. Hum. Genet. 79, 549-555 doi:10.1086/507047
188. Voutsadakis, I.A. (2013) Ubiquitin- and ubiquitin-like proteins-conjugating enzymes (E2s) in breast cancer. Mol. Biol. Rep. 40, 2019-2034 doi:10.1007/ s11033-012-2261-0
189. Mulder, M.P., Witting, K., Berlin, I., Pruneda, J.N., Wu, K.P., Chang, J.G. et al. (2016) A cascading activity-based probe sequentially targets E1-E2-E3 ubiquitin enzymes. Nat. Chem. Biol 12, 523-530 doi:10.1038/nchembio.2084
190. Pao, K.-C., Stanley, M., Han, C., Lai, Y.-C., Murphy, P., Balk, K. et al. (2016) Probes of ubiquitin E3 ligases enable systematic dissection of parkin activation. Nat. Chem. Biol. 12, 324-331 doi:10.1038/nchembio.2045